These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 17484634)

  • 21. Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department.
    Ray P; Delerme S; Jourdain P; Chenevier-Gobeaux C
    QJM; 2008 Nov; 101(11):831-43. PubMed ID: 18664534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR; Oyama MA; Reynolds C; Rush JE; DeFrancesco TC; Keene BW; Atkins CE; Macdonald KA; Schober KE; Bonagura JD; Stepien RL; Kellihan HB; Nguyenba TP; Lehmkuhl LB; Lefbom BK; Moise NS; Hogan DF
    J Vet Cardiol; 2009 May; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic utility of N-terminal-proBNP in differentiating acute pulmonary embolism from heart failure in patients with acute dyspnea.
    Guo L; Li G; Wang Y; Liang H; Shan X; Zhang N; Wang M; Lin D; Zhu L
    Chin Med J (Engl); 2014; 127(16):2888-93. PubMed ID: 25131222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
    Behnes M; Brueckmann M; Ahmad-Nejad P; Lang S; Wolpert C; Elmas E; Kaelsch T; Gruettner J; Weiss C; Borggrefe M; Neumaier M
    Int J Cardiol; 2009 Jun; 135(2):165-74. PubMed ID: 18603317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natriuretic peptides as markers of mild forms of left ventricular dysfunction: effects of assays on diagnostic performance of markers.
    Hammerer-Lercher A; Ludwig W; Falkensammer G; Müller S; Neubauer E; Puschendorf B; Pachinger O; Mair J
    Clin Chem; 2004 Jul; 50(7):1174-83. PubMed ID: 15142976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study).
    O'Donoghue M; Kenney P; Oestreicher E; Anwaruddin S; Baggish AL; Krauser DG; Chen A; Tung R; Cameron R; Januzzi JL
    Am J Cardiol; 2007 Nov; 100(9):1336-40. PubMed ID: 17950786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Head-to-head comparison of the prohormone proBNP1-108 with BNP and Nt-proBNP in patients admitted to emergency department.
    Gruson D; Ketelslegers JM; Verschuren F; Thys F
    Clin Biochem; 2012 Feb; 45(3):249-52. PubMed ID: 22209994
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma BNP and NT-proBNP assays by automated immunoanalyzers: analytical and clinical study.
    Bionda C; Bergerot C; Ardail D; Rodriguez-Lafrasse C; Rousson R
    Ann Clin Lab Sci; 2006; 36(3):299-306. PubMed ID: 16951271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The N-terminal Pro-BNP investigation of dyspnea in the emergency department (PRIDE) study.
    Januzzi JL; Camargo CA; Anwaruddin S; Baggish AL; Chen AA; Krauser DG; Tung R; Cameron R; Nagurney JT; Chae CU; Lloyd-Jones DM; Brown DF; Foran-Melanson S; Sluss PM; Lee-Lewandrowski E; Lewandrowski KB
    Am J Cardiol; 2005 Apr; 95(8):948-54. PubMed ID: 15820160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency department.
    Siebert U; Januzzi JL; Beinfeld MT; Cameron R; Gazelle GS
    Am J Cardiol; 2006 Sep; 98(6):800-5. PubMed ID: 16950189
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PATHFAST NT-proBNP (N-terminal-pro B type natriuretic peptide): a multicenter evaluation of a new point-of-care assay.
    Zaninotto M; Mion MM; Di Serio F; Caputo M; Ottomano C; Plebani M
    Clin Chem Lab Med; 2010 Jul; 48(7):1029-34. PubMed ID: 20406130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure.
    Omland T
    Crit Care Med; 2008 Jan; 36(1 Suppl):S17-27. PubMed ID: 18158473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of capillary B-type natriuretic peptide testing.
    Schreinlechner M; Mrakovic A; Laschober G; Mayerl C; Griesmacher A; van Lippen L; Semjonow V; Nieuwenhuis J; van Reenen A; Mair J
    Clin Chem Lab Med; 2020 Mar; 58(4):618-624. PubMed ID: 31804953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of N-terminal prohormone brain natriuretic peptide assay for etiologic diagnosis of acute dyspnea in elderly patients.
    Berdagué P; Caffin PY; Barazer I; Vergnes C; Sedighian S; Letrillard S; Pilossof R; Goutorbe F; Piot C; Reny JL
    Am Heart J; 2006 Mar; 151(3):690-8. PubMed ID: 16504634
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [BNP or NT-proBNP: "that is the question"].
    Lebrun C; Neuder Y; Pison C; Chouri N; Barnoud D; Belle L; Beaune G
    Ann Biol Clin (Paris); 2007; 65(5):533-8. PubMed ID: 17913672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cautious application of pleural N-terminal pro-B-type natriuretic peptide in diagnosis of congestive heart failure pleural effusions among critically ill patients.
    Yeh JH; Huang CT; Liu CH; Ruan SY; Tsai YJ; Chien YC; Yang CY; Huang CK; Hsu CL; Kuo LC; Lee PL; Ku SC; Kuo PH; Yu CJ;
    PLoS One; 2014; 9(12):e115301. PubMed ID: 25502236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age.
    Koch AM; Rauh M; Zink S; Singer H
    Acta Paediatr; 2006 Jul; 95(7):805-9. PubMed ID: 16801175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of B type natriuretic peptides with clinical and echocardiographic parameters in heterogeneous population of patients with symptoms suggestive of heart failure.
    Piechota WN; Piechota WT; Bejm J; Wierzbowski R; Michałkiewicz D
    Adv Med Sci; 2006; 51():164-7. PubMed ID: 17357300
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Natriuretic peptides--new diagnostic markers in heart disease].
    Angermann CE; Ertl G
    Herz; 2004 Sep; 29(6):609-17. PubMed ID: 15912436
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of compensated renal dysfunction on approved heart failure markers: direct comparison of brain natriuretic peptide (BNP) and N-terminal pro-BNP.
    Luchner A; Hengstenberg C; Löwel H; Riegger GA; Schunkert H; Holmer S
    Hypertension; 2005 Jul; 46(1):118-23. PubMed ID: 15939804
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.